Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? (Q48838612)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2010

Language	Label	Description	Also known as
English	Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?	scientific article published in August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

0 references

quality of life

1 reference

based on heuristic

inferred from title

Florian Seemüller

17

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Hans-Jürgen Möller

18

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

Joachim Klosterkötter

10

object named as

Joachim Klosterkötter

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

19

object named as

Michael Riedel

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Isabella Heuser

11

object named as

Isabella Heuser

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Michael Obermeier

3

object named as

Michael Obermeier

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Rebecca Schennach-Wolff

1

object named as

Rebecca Schennach-Wolff

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Stefan Klingberg

15

object named as

Stefan Klingberg

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

4

object named as

Max Schmauss

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

author name string

Markus Jäger

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Gerd Laux

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Herbert Pfeiffer

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Dieter Naber

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Lutz G Schmidt

8

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Wolfgang Gaebel

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Kai-Uwe Kühn

12

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Matthias R Lemke

13

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Eckart Rüther

14

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Markus Gastpar

16

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

11

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

729-738

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Remission in schizophrenia: proposed criteria and rationale for consensus

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Quality of life measures in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Predictors of long-term outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Patient well-being after general anaesthesia: a prospective, randomized, controlled multi-centre trial comparing intravenous and inhalation anaesthesia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Unbiased Recursive Partitioning: A Conditional Inference Framework

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Compliance therapy in psychotic patients: randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Subjective and objective quality of life in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Standardized remission criteria in schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

SF-36 health survey update

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life

1 reference

https://api.crossref.org/works/10.3109%2F15622971003690289

21 January 2018

Identifiers

10.3109/15622971003690289

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/20380620

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48838612&oldid=1741923310"